SCOPUS 정보 검색 플랫폼

Psychiatric Genetics

Volumn 12, Issue 1, 2002, Pages 55-58

CYP2D6 polymorphisms and atypical antipsychotic weight gain

(5) Ellingrod, Vicki L a,d Miller, Del b Schultz, Susan K b Wehring, Heidi a Arndt, Stephan b,c

a UNIVERSITY OF IOWA (United States)

b Division of Cardiac Anesthesia (United States)

c UNIVERSITY OF IOWA (United States)

d BCPP (United States)

Author keywords

Atypical antipsychotics; CYP2D6; Olanzapine; Polymorphism; Weight gain

Indexed keywords

CYTOCHROME P450 2D6; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ARTICLE; BODY MASS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LINEAR REGRESSION ANALYSIS; MORBIDITY; OBESITY; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL ANALYSIS; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; CYTOCHROME P-450 CYP2D6; HETEROZYGOTE; HOMOZYGOTE; HUMANS; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 0036220488 PISSN: 09558829 EISSN: None Source Type: Journal
DOI: 10.1097/00041444-200203000-00008 Document Type: Article

Times cited : (70)

References (24)

1
- 0032751075
- Antipsychotic-induced weight gain: A comprehensive research synthesis
- (1999) Am J Psychiatry , vol.156 , pp. 1686-1696
- Allison, D.B.¹ Mentore, J.L.² Moonseon, H.³ Chandler, L.P.⁴ Cappelleri, J.C.⁵ Infante, M.C.⁶ Weiden, P.J.⁷

2
- 0004235298
- Washington DC: American Psychiatric Association
- (1987) Diagnostic and Statistical Manual of Mental Disorders. Third edition, revised

3
- 0004235298
- Washington DC: American Psychiatric Association
- (1994) Diagnostic and Statistical Manual of Mental Disorders. Fourth edition

4
- 0004171473
- Iowa City, IA: The University of Iowa
- (1982) Scale for the Assessment of Negative Symptoms (SANS)
- Andreasen, N.¹

5
- 0004171473
- Iowa City, IA: The University of Iowa
- (1983) Scale for the Assessment of Positive Symptoms (SAPS)
- Andreasen, N.¹

6
- 0026665649
- The comprehensive assessment of symptoms and history (CASH): An instrument assessing psychopathology and diagnoses
- (1992) Arch Gen Psychiatry , vol.49 , pp. 615-623
- Andreasen, N.C.¹ Flaum, M.² Arndt, S.³

7
- 4243393034
- Basel: Karger
- (1990) Evidence for the Validity of Negative Symptoms in Schizophrenia: Positive and Negative Symptoms and Syndromes
- Barnes, T.R.E.¹ Liddle, P.F.²

8
- 0032980471
- Metabolism, pharmacogenetics, and metabolic drug-drug interactions of antipsychotic drugs
- (1999) Cell Mol Neurobiol , vol.19 , pp. 419-510
- Fang, J.¹ Gorrod, J.W.²

9
- 0024236331
- The molecular biology of cytochrome P450s
- (1990) Pharmacol Rev , vol.40 , pp. 243-288
- Gonzalez, F.J.¹

10
- 0003776726
- Publication (ADH) 76-338. Washington, DC: US Department of Health, Education, and Welfare, ECDEU
- (1976) Abnormal Involuntary Movement Scale: Assessment Manual for Psychopharmacology , pp. 534-537
- Guy, W.¹

11
- 0025080352
- Genotyping of poor metabolizer of debrisoquine by allele-specific PCR amplification
- (1990) Lancet , vol.336 , pp. 529-532
- Heim, M.¹ Meyer, U.A.²

12
- 0028835191
- Weight gain induced by clozapine
- (1995) Eur Neuropsychopharmacol , vol.5 , pp. 437-440
- Hummer, M.¹ Kemmler, G.² Kurz, M.³ Kurzthaler, I.⁴ Oberbauer, H.⁵ Fleischhacker, W.W.⁶

13
- 0031030609
- Disposition and biotransformation of the antipsychotic agent olanzapine in humans
- (1997) Drug Metab Dispos , vol.25 , pp. 81-93
- Kassahun, K.¹ Mattiuz, E.² Nyhart Jr., E.³ Obermeyer, B.⁴ Gillespie, T.⁵ Murphy, A.⁶

14
- 0026080111
- A rapid non-enzymatic method for the preparation of HMV DNA from blood for RFLP analysis
- (1991) Nucl Acids Res , vol.19 , pp. 5444
- Lahiri, D.K.¹ Nurnburger Jr., J.I.²

15
- 2042485508
- Bethesda MA: US Department of Health and Human Services
- (2000) NIH publication No. 00-0484

16
- 0033055756
- Olanzapine serum concentrations in psychiatric patients given standard doses: The influence of comedication
- (1999) Ther Drug Monitor , vol.21 , pp. 87-90
- Olesen, O.V.¹ Linnet, K.²

17
- 0000503515
- Brief psychiatric rating scale
- (1962) Psychol Rep , vol.10 , pp. 799-812
- Overall, J.¹ Gorham, D.²

18
- 0030077735
- Identification of human cytochrome P450 responsible for the in vitro formation of the major oxidative metabolite of the antipsychotic agent olanzapine in humans
- (1996) J Pharmacol Exper Ther , vol.276 , pp. 658-666
- Ring, B.J.¹ Catlow, J.² Lindsay, T.J.³ Gillespie, T.⁴ Roskos, L.K.⁵ Cerimele, B.J.⁶

19
- 0014723449
- A rating scale for extrapyramidal effects
- (1970) Acta Psychiatr Scand , vol.45 , Issue.SUPPL. 212 , pp. 11-12
- Simpson, G.M.¹ Angus, J.W.²

20
- 0030993030
- Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
- (1997) Am J Psychiatry , vol.154 , pp. 457-465
- Tollefson, G.D.¹ Beasley, C.M.² Tran, P.V.³ Street, J.S.⁴ Kruger, J.A.⁵ Tamura, R.N.⁶

21
- 0029821861
- Medical complications of new antipsychotic drugs
- (1996) Schizophr Bull , vol.22 , pp. 475-483
- Umbricht, D.¹ Kane, J.M.²

22
- 0035153224
- Bodyweight gain with atypical antipsychotics
- (2001) Drug Safety , vol.24 , pp. 59-73
- Wetterling, T.¹

23
- 0344348977
- Weight gain: Side effect of atypical neuroleptics?
- (1999) J Clin Psychopharmacol , vol.19 , pp. 316-321
- Wetterling, T.¹ Mussigbrodt, H.E.²

24
- 0033037295
- Novel antipsychotics: Comparison of weight gain liabilities
- (1999) J Clin Psychiatry , vol.60 , pp. 358-363
- Wirshing, D.A.¹ Wirshing, W.C.² Kysar, L.³ Berisford, M.A.⁴ Goldstein, D.⁵ Pashdag, J.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.